U.S. Electronic Equipment and Components Stock News

NasdaqCM:AKBA
NasdaqCM:AKBABiotechs

Akebia Therapeutics (AKBA) Is Down 14.5% After Swing To Q1 Loss And Share Increase Plan

Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss of US$9.05 million replacing prior net income of US$6.11 million. A recent proposal to increase authorized capital stock to 525,000,000 shares, including 500,000,000 common shares, adds a potential dilution and financing angle to Akebia’s weaker quarterly performance. Next, we’ll examine how the shift to a quarterly loss alongside...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

A Look At JetBlue Airways (JBLU) Valuation As Card Refresh And Fort Lauderdale Expansion Advance

Credit card refresh and Fort Lauderdale build out take center stage JetBlue Airways (JBLU) has put its co branded JetBlue Premier World Elite Mastercard and Fort Lauderdale expansion at the heart of its current push to win and retain travelers after Spirit Airlines’ shutdown. The card now offers larger statement credits, status related tile bonuses and a sizable limited time TrueBlue points offer. Fort Lauderdale is set to see new routes, added frequencies and targeted perks for former Spirit...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Is GitLab (GTLB) Now Attractive After Sharp Share Price Declines This Year?

If you are wondering whether GitLab at around US$25.92 is priced attractively or not, the key is understanding what the current valuation is actually baking in for the future. The stock has recently been volatile, with a 17.1% return over the last 7 days and 12.0% over the last 30 days, yet it still sits on a year to date return of 28.4% decline and a 1 year return of 47.7% decline. Recent coverage has focused on GitLab as a software platform positioned in a competitive developer tools...
NYSE:MET
NYSE:METInsurance

Is MetLife (MET) Offering Value After Recent 10.7% Share Price Gain?

If you are wondering whether MetLife at around US$78.82 offers fair value or a margin of safety, this article explains what the current price might be indicating. The stock has returned 10.7% over the last 30 days, while the 1-year return is 3.8% and the 3-year return is 67.2%. These figures can influence how investors view both potential upside and risk. Recent coverage has highlighted MetLife's position as a major US insurance company. Investors have been focusing on how interest rate...
NYSE:UGI
NYSE:UGIGas Utilities

Is It Time To Reassess UGI (UGI) After Its Recent Share Price Weakness

If you are wondering whether UGI is attractively priced or just a value trap, starting with the current share price and valuation checks can help frame the picture. UGI closed at US$32.32, with recent returns showing a 10.4% decline over 7 days, 12.7% over 30 days, 14.1% year to date, and 3.6% over 1 year. This is set against a 31.7% gain over 3 years and an 11.3% decline over 5 years. These mixed return figures sit alongside ongoing investor attention on UGI as a regulated utility and...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

Airbnb (ABNB) Margin Compression Challenges Bullish Profitability Narratives After FY 2025 Results

Airbnb (ABNB) has wrapped up FY 2025 with fourth quarter revenue of US$2.8b and basic EPS of US$0.56, capping a year where trailing twelve month revenue reached US$12.2b and EPS came in at US$4.10. Over the past few quarters, revenue has moved from US$2.5b in Q4 2024 to US$4.1b in Q3 2025 before landing at US$2.8b in Q4 2025. Over the same stretch, quarterly EPS shifted from US$0.74 to US$2.25 and then to US$0.56, giving investors a clearer view of how profitability tracks Airbnb’s seasonally...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Why Advanced Energy Industries (AEIS) Is Down 8.3% After Q1 Beat, Higher Guidance and Capital Moves - And What's Next

Advanced Energy Industries recently reported first-quarter 2026 results showing sales of US$511.0 million and diluted EPS from continuing operations of US$1.58, alongside confirming a US$0.10 quarterly dividend and updating second-quarter guidance. The company also completed a multi‑year share repurchase program, filed new shelf registrations for up to 3.0 million ESOP‑related shares, and signaled an active acquisition pipeline supported by what management describes as a strong balance...
NYSE:AWK
NYSE:AWKWater Utilities

Should American Water’s Q1 Earnings, Dividend Hike and Service Investments Require Action From AWK Investors?

In the past quarter, American Water Works Company, Inc. reported first-quarter 2026 sales of US$1,207 million, with net income of US$196 million and basic earnings per share from continuing operations of US$1, while also declaring a quarterly dividend of US$0.895 per share payable on June 2, 2026. Alongside these financial results, the company has been recognized for workplace culture and customer satisfaction and continued to invest in water quality, infrastructure, and community programs...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape Starts Eagle Line As Licensing Revenue Story Begins

QuantumScape (NasdaqGS:QS) has started operations at its Eagle Line pilot-scale solid-state battery production facility. The company has recorded its first billings from ecosystem partners, initiating its licensing and royalty revenue stream. These developments represent a shift from pure development work to initial commercialization and monetization of its battery technology. QuantumScape focuses on solid-state lithium-metal batteries aimed at electric vehicles and related applications, a...
NYSE:BIRK
NYSE:BIRKLuxury

Is It Time To Revisit Birkenstock Holding (BIRK) After Recent Share Price Pullback

If you are wondering whether Birkenstock Holding stock is attractively priced or still too expensive for your portfolio, this article breaks down what the current valuation implies. The stock last closed at US$39.04, with recent returns of 0.8% over 7 days, 12.6% over 30 days, and a 6.5% decline year to date, alongside a 25.6% decline over the last year. Recent coverage around Birkenstock Holding has focused on its position in the consumer durables space and how investors are weighing brand...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue

Amphastar Pharmaceuticals (AMPH) closed out FY 2025 with fourth quarter revenue of US$183.1 million and basic EPS of US$0.53, compared with prior year Q4 revenue of US$186.5 million and EPS of US$0.79, as trailing net profit margin moved from 21.8% to 13.6% over the last 12 months. Over the past six reported quarters, revenue has remained within a relatively narrow range of roughly US$170 million to US$192 million per quarter, while EPS has ranged from US$0.37 to US$0.83, giving investors a...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Did Accelerated NRC Approval of Aurora Design Criteria Just Shift Oklo's (OKLO) Investment Narrative?

In early May 2026, Oklo Inc. reported that the U.S. Nuclear Regulatory Commission approved its Principal Design Criteria topical report for the Aurora powerhouse in Idaho on an accelerated timeline, establishing the core safety, reliability and performance requirements that can be referenced in future licensing applications. This rapid approval materially reduces repetitive regulatory review for Oklo’s advanced reactors and signals that federal modernization efforts are beginning to...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite FedRAMP Win Raises Questions On Undervalued Stock Weak Momentum

Cellebrite DI's Cellebrite Government Cloud platform has received FedRAMP High Authorization, the top federal cloud security standard. The U.S. Department of Justice acted as the sponsoring agency for this authorization. The approval covers handling of highly sensitive unclassified data for federal agencies. Cellebrite DI (NasdaqGS:CLBT) now has its Cellebrite Government Cloud cleared at the FedRAMP High level, placing it among a relatively small group of vendors that meet the federal...
NYSE:FTV
NYSE:FTVMachinery

Is It Too Late To Consider Fortive (FTV) After Its Recent Share Price Climb?

If you are wondering whether Fortive at around US$60.90 is still a fair deal or already pricing in the story, this breakdown will help you size up what you are really paying for the stock. Over the shorter term, Fortive has posted returns of 1.9% over the last week, 7.1% over the last month, 9.9% year to date and 16.3% over the past year, which raises questions about how much of the current valuation is already reflected in the recent share price. Recent attention on Fortive has centered on...
NYSE:BRC
NYSE:BRCCommercial Services

Is It Too Late To Consider Brady (BRC) After Recent Share Price Weakness?

For investors wondering if Brady's current share price still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are really saying about the stock. Brady closed at US$79.53, with a 2.8% decline over the last 7 days and a 1.0% decline over 30 days, while still showing returns of 1.1% year to date and 9.9% over the last year. These price moves sit against a backdrop of ongoing investor interest in Commercial Services companies like Brady...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) Too Expensive After Recent 97% One-Year Share Price Surge

GLOBALFOUNDRIES stock might already be on your radar, but if you are wondering whether the recent excitement is backed up by value or just momentum, this is where the valuation story starts to take shape. At a last close of US$70.93, the stock shows returns of 9.8% over 7 days, 61.5% over 30 days, 92.4% year to date and 97.4% over the past year. This raises fair questions about how much future upside or downside is already reflected in the price. Recent coverage has focused on GLOBALFOUNDRIES...
NYSE:KWR
NYSE:KWRChemicals

A Look At Quaker Chemical (KWR) Valuation After Recent Share Price Momentum

Why Quaker Chemical (KWR) is Getting Fresh Attention Quaker Chemical (KWR) has caught fresh attention after recent share price moves, with the stock showing mixed returns over the past year, which prompts a closer look at its fundamentals and regional revenue mix. See our latest analysis for Quaker Chemical. The recent 16.88% 1 month share price return, on top of a 5.19% 7 day share price gain, contrasts with a 15.95% 3 month share price decline and mixed multi year total shareholder returns...
NasdaqGS:NWPX
NasdaqGS:NWPXConstruction

NWPX Infrastructure (NWPX) Is Up 11.3% After EPS More Than Doubles In Q1 2026 Results

NWPX Infrastructure, Inc. has already reported first-quarter 2026 results, with revenue of US$138.25 million and net income of US$10.53 million, alongside continued execution of its share repurchase program through March 31. The sharp rise in earnings per share from continuing operations, with basic EPS moving to US$1.10 from US$0.40 a year earlier, underscores how recent performance may be reshaping perceptions of the business. With earnings per share more than doubling year on year, we’ll...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Uranium Energy Starts Burke Hollow Production With Valuation Upside In Focus

Uranium Energy has started production at its Burke Hollow project, the first new U.S. in situ recovery uranium mine in more than a decade. The company has secured key regulatory approvals that support current output and future capacity at Burke Hollow. This step positions Uranium Energy as a leading domestic producer at a time when U.S. uranium supply is drawing more attention. Uranium Energy (NYSEAM:UEC) is drawing fresh attention with Burke Hollow moving into production and key permits...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Assessing Geron (GERN) Valuation After Q1 2026 Earnings Beat And RYTELO Growth Progress

Geron (GERN) is back in focus after its Q1 2026 earnings, where revenue and loss per share came in ahead of expectations, supported by RYTELO growth, reiterated full-year guidance, and pipeline updates. See our latest analysis for Geron. Despite the stronger Q1 update, Geron’s 1-day share price return of a 7.6% decline and 1-month share price return of a 16.1% decline suggest fading near-term momentum, while the 1-year total shareholder return of 15.9% and 3-year total shareholder return of a...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Jumia Technologies (JMIA) Losses Narrow In Q4 2025 Challenging Bearish Profitability Narratives

Jumia Technologies (NYSE:JMIA) just wrapped up FY 2025 with Q4 revenue of US$61.4 million and a basic EPS loss of US$0.08, alongside a trailing 12 month revenue base of US$188.9 million and a loss of US$61.6 million. Over the past six reported quarters, revenue has moved from US$36.3 million in Q1 2025 to US$61.4 million in Q4 2025, while quarterly net losses ranged between US$10.3 million and US$19.5 million. This sets the stage for a story that now hinges on how quickly margins can tighten...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

Energy Recovery (ERII) Is Down 14.8% After Pulling 2026 Guidance And Announcing Leadership Changes

In the first quarter of 2026, Energy Recovery, Inc. reported sales of US$9.71 million, a wider net loss of US$12.25 million, a US$1.66 million goodwill impairment, and announced upcoming CEO retirement alongside the resignation of its CFO. The company also withdrew its 2026 financial guidance amid Middle East uncertainty, even as new product launches and desalination demand supported revenue growth. Next, we’ll examine how the withdrawal of 2026 guidance reshapes Energy Recovery’s investment...
NYSE:CMP
NYSE:CMPMetals and Mining

Is Compass Minerals (CMP) Now Stretched After Its Strong 57% One-Year Share Price Rally?

Wondering if Compass Minerals International at US$28.24 is genuinely good value or just riding a trend? This article breaks down what the current price could mean for you. The stock has returned 5.7% over the last 7 days, 23.1% over the last 30 days, 42.2% year to date and 57.2% over the last year. The 3 year and 5 year returns sit at 10.9% and 56.2% declines respectively. Recent coverage has focused on Compass Minerals International's position within the broader materials sector and how...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Phathom (PHAT) Is Up 9.4% After Reaffirming 2026 Profitability Timeline And Narrowing Q1 Loss

In late April 2026, Phathom Pharmaceuticals reported that its first-quarter net loss narrowed to US$30.37 million from US$94.32 million a year earlier, while maintaining full-year 2026 net revenue guidance of US$320 million to US$345 million and expecting operating profitability, excluding stock-based compensation, to begin in the third quarter of 2026. The company also disclosed a change in how it classifies certain third-party costs starting January 1, 2026, which could make future margins...